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leaﬂ  et associated with the vegetation 
was destroyed. The vegetation culture, 
pericardial ﬂ  uid culture, tissue culture 
from the resected mitral valve, and 
3 blood cultures yielded no bacterial 
growth.
The patient required ventilator 
support for 7 days. Follow-up com-
puted tomography on day 8 showed 
a stable appearance of cerebral in-
farcts. Coumadin was started to pre-
vent thrombus development at the 
prosthetic valve. He went home after 
completing a 4-week treatment course 
of ceftriaxone. At that time, there was 
still noticeable left-sided weakness of 
the extremities. He could only com-
municate by using eye movements 
with no verbal response.
During the 20th century inﬂ  uenza 
pandemics, secondary bacterial pneu-
monia was a notable cause of death. 
The current pandemic (H1N1) 2009 
outbreak is evolving rapidly, and it is 
unknown if pandemic (H1N1) 2009 
may lead to an increase in rare com-
plications of pneumococcal infection, 
such as endocarditis. Thus, Austrian 
syndrome should be considered in any 
patient with pandemic (H1N1) 2009 
complicated by pneumococcal infec-
tion and a new heart murmur. 
Waseem Alhushki 
and Chokechai Rongkavilit
Author afﬁ   liation: Wayne State University, 
Detroit, Michigan, USA  
DOI: 10.3201/eid1609.091779
References
  1.   Austrian  R.  Pneumococcal  endocarditis, 
meningitis, and rupture of the aortic valve. 
AMA Arch Intern Med. 1957;99:539–44.
    2.    Rammeloo L, Hruda J, Sobotka-Plojhar 
M, Avis W, Schoof P. Austrian syndrome 
in a child—aortic valve endocarditis fol-
lowing pneumococcal meningitis. Int J 
Cardiol. 2004;94:321–2. DOI: 10.1016/j.
ijcard.2003.03.025
    3.   Aronin SI, Mukherjee SK, West JC, 
Cooney EL. Review of pneumococcal 
endocarditis in adults in the penicillin era. 
Clin Infect Dis. 1998;26:165–71. DOI: 
10.1086/516279
    4.   Lefort A, Mainardi JL, Selton-Suty C, 
Casassus P, Guillevin L, Lortholary O. 
Streptococcus pneumoniae endocarditis 
in adults. A multicenter study in France 
in the era of penicillin resistance (1991–
1998). The Pneumococcal Endocardi-
tis Study Group. Medicine (Baltimore). 
2000;79:327–37. DOI: 10.1097/00005792-
200009000-00006
Address for correspondence: Waseem Alhushki,   
Children’s Hospital of Michigan, 3901 
Beaubien Blvd, Detroit, MI 48201 USA; email: 
walhushk@dmc.org
Rickettsia sibirica 
mongolitimonae 
in Traveler from 
Egypt
To the Editor: Tick-borne rick-
ettsioses are zoonoses caused by spot-
ted fever group (SFG) Rickettsia spp. 
(1), which have been reported as a fre-
quent cause of fever in international 
travelers (2). In Egypt, Mediterranean 
spotted fever caused by Rickettsia 
conorii transmitted by the brown dog 
tick,  Rhipicephalus sanguineus, is 
known to be present, although cases 
are rarely documented. Moreover, an 
emerging pathogen, R. aeschlimannii, 
has been detected in Hyalomma drom-
edarii ticks, collected from camels, 
and in H. impeltatum and H. margin-
atum ruﬁ  pes, collected from cows (3). 
We report a case of Rickettsia sibirica 
mongolitimonae infection in a French 
traveler who returned from Egypt 
In September 2009, a previously 
healthy 52-year-old man living in 
France was admitted to the infectious 
diseases unit of a hospital in Nantes, 
France, with a 10-day history of fever, 
asthenia, headache, and arthromyal-
gia. Three days earlier, he had returned 
from a 2-week trip to Egypt. He had 
fever (38°C), painful axillary lymph-
adenopathies, and an inoculation es-
char surrounded by an inﬂ  ammatory 
halo on the left scapular area (online 
Appendix Figure, www.cdc.gov/EID/
content/16/9/1495-appF.htm), but he 
did not have a rash. During his travel, 
he had been unsuccessfully treated for 
headache, arthromyalgia, and diarrhea 
by amoxicillin-clavulanate (3 g/d), 
nonsteroidal antiinﬂ  ammatory  drugs, 
and gentamicin cream on the eschar 
for 3 d. No tick bite was reported by 
the patient. We suspected an SFG rick-
ettsiosis. The patient received 200 mg 
doxycycline in a single dose and rap-
idly improved.
The immunoﬂ  uorescence  assay 
for antibodies reactive against SFG 
antigens showed increased levels of 
immunoglobulin M (titer 16) and G 
(titer 128). Results of Western blot 
with cross-adsorption assays support-
ed the hypothesis that  the infection 
was caused by R. sibirica mongoli-
timonae (1). To identify the involved 
rickettsiae, PCR ampliﬁ  cations  and 
sequencing  gltA,  ompA, and ompB 
fragment genes of Rickettsia spp. and 
multispacer typing (MST), based on 
the sequence of variable intergenic 
spacers, were performed by using 
DNA samples obtained from an es-
char biopsy and a lesion swab (4,5). 
A negative control (sterile water and 
DNA from a sterile biopsy speci-
men) and a positive control (DNA 
from R. montanensis) were included 
in each test. Amplicon sequencing 
conﬁ  rmed the presence of R. sibiri-
ca mongolitimonae DNA in patient 
samples. The sequence homology 
to R. sibirica mongolitimonae DNA 
was ompA, 99.4%; gltA, 99.7%; and 
ompB, 100% (GenBank accession 
nos. DQ097082, DQ097081, and 
AF123715, respectively). The MST 
sequences were 100% homologous to 
the genotype of R. sibirica mongoli-
timonae MST type U (idem HA-91). 
We injected shell vial cultures with 
eschar biopsy specimens (4). Fifteen 
days later, positive Gimenez staining 
and immunoﬂ  uorescence  conﬁ  rmed 
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the presence of Rickettsia sp. in cell 
culture, and R. sibirica mongoliti-
monae was identiﬁ  ed by PCR and se-
quencing as described above (online 
Appendix Figure).
R. sibirica mongolitimonae was 
ﬁ  rst isolated in Beijing in 1991 from 
H. asiaticum ticks (formerly named 
R. sibirica HA-91), and the ﬁ  rst hu-
man infection was reported in 1996 
(4). Since that time, R. sibirica mon-
golitimonae infections have been 
diagnosed in 15 additional patients: 
12 from Europe (France, Portugal, 
Greece, and Spain) and 3 from Africa 
(Algeria, South Africa, and the pres-
ent patient who returned from Egypt). 
The application of genotypic criteria 
to R. sibirica mongolitimonae classi-
ﬁ  ed the organism as a subspecies of 
R. sibirica group, in spite of its dis-
tinct serotypes and speciﬁ  c epidemio-
logic features compared to R. sibirica 
sibirica, the causative agent of Sibe-
rian tick typhus or North Asian tick 
typhus (1).
R. sibirica mongolitimonae 
causes lymphangitis-associated rick-
ettsiosis. The available clinical fea-
tures for the only 16 reported cases 
(10 men, 6 women) include fever in all 
patients (range 38˚C–39.5°C), chills 
(3/16 patients), headache (13/16), 
myalgia (13/16), arthralgia (3/16), cu-
taneous rash (11/16), enlarged lymph 
nodes (10/16), lymphangitis expand-
ing from an inoculation eschar to 
the draining node (6/16), and retinal 
vasculitis in a pregnant woman (6,7). 
Two patients exhibited 2 eschars. 
Most eschars were on the legs, but 
some patients had an eschar on the 
back, the abdomen, the arm, or the 
face. The patients’ median age was 
50 years (range 20–76 years). A tick 
bite or tick handling was reported for 
5 patients, but no tick was collected 
for further examination. In France, 
7 patients probably came in contact 
with  R. sibirica mongolitimonae–
infected ticks in their gardens, and 2 
other patients were probably exposed 
during a walk in the Camargue Na-
tional Park, where migratory birds 
are frequently present (7). Infection 
with R. sibirica mongolitimonae oc-
curred primarily between March and 
September. A single case was report-
ed in December in Greece. R. sibirica 
mongolitimonae has been detected in 
several Hyalomma spp. ticks in Ni-
ger, Greece, the People’s Republic of 
China, Senegal, and in Rh. pusillus 
ticks in Portugal (6–8). Although Hy-
alomma spp. ticks seem to be associ-
ated with R. sibirica mongolitimonae, 
more experimental data are needed to 
determine the tick vectors and reser-
voirs of this rickettsia.
Clinicians in Egypt and those 
who may see patients returning from 
this country should be aware that sev-
eral species of rickettsiae are found in 
this region. Thus, they should consider 
a range of SFG rickettsial diseases in 
the differential diagnosis of patients 
with febrile illnesses.
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Increase in 
Neisseria 
meningitidis 
Serogroup W135, 
Niger, 2010 
To the Editor: Meningococcal 
epidemics in the African meningitis 
belt are generally caused by Neisseria 
meningitidis serogroup A strains, but 
they also can be caused by serogroup 
W135 or X strains. The largest reported 
outbreak caused by serogroup W135 
occurred in Burkina Faso in 2002 with 
≈13,000 suspected cases (1). Spo-
radic cases of meningitis caused by 
serogroup W135 have, however, been 
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